Yesterday, Goldman Sachs removed Eli Lilly from its conviction sell list. In the past few weeks shares of Eli Lilly have rallied nearly 15% while the market has rallied 5%. This was the second time this year I was able to make a very nice profit by buying stocks on Goldman's conviction sell list. The first was American Express at $10.
Goldman Sachs is a top notch firm that knows how to make money. However, they don't make money from eating their own cooking. Not when it comes to equity research.